TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  The Motley Fool

A 10% Owner Of Structure Therapeutics Shed Shares

The Motley Fool Logo The Motley Fool By Adé Hennis
A 10% Owner Of Structure Therapeutics Shed Shares

FMR LLC, a Johnson family-controlled company and 10% owner of Structure Therapeutics, sold 52,356 shares worth approximately $3.8 million on December 8, 2025. Despite this insider sale, the clinical-stage biopharmaceutical company's stock has surged 212.55% over the past year, with continued momentum in 2026. The company recently closed a $748 million public offering and is developing a competitive weight loss pill.

Insights
GPCR   positive

Despite insider selling by a major shareholder, the stock has demonstrated exceptional performance with 212.55% one-year returns and continued bullish momentum. The company successfully closed a $748 million public offering, has strong investor support, and is developing a competitive weight loss therapy. The insider sale appears to be a partial position reduction rather than a loss of confidence.